Global Alpha Capital Management Ltd. Pacira Bio Sciences, Inc. Transaction History
Global Alpha Capital Management Ltd.
- $1.38 Billion
- Q4 2024
A detailed history of Global Alpha Capital Management Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 39,900 shares of PCRX stock, worth $993,909. This represents 0.05% of its overall portfolio holdings.
Number of Shares
39,900
Previous 37,740
5.72%
Holding current value
$993,909
Previous $568,000
32.22%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
49.3MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$131 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$81.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$56.2 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$49.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...